Litigation Details for SENJU PHARMACEUTICAL CO., LTD. v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2018)
✉ Email this page to a colleague
SENJU PHARMACEUTICAL CO., LTD. v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-12-06 |
Court | District Court, D. New Jersey | Date Terminated | 2019-01-02 |
Cause | 35:271 Patent Infringement | Assigned To | Brian R. Martinotti |
Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
Patents | 10,085,958; 8,669,290; 8,871,813; 9,144,609; 9,517,220; 9,561,277 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SENJU PHARMACEUTICAL CO., LTD. v. AMNEAL PHARMACEUTICALS LLC
Details for SENJU PHARMACEUTICAL CO., LTD. v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-12-06 | 1 | United States Patent No. 10,085,958 (“the ’958 patent”) arising under the United States patent laws, Title… THE PATENT IN SUIT 18. The PTO issued the ’958 patent on October 2, 2018. …Holdings is the assignee of the ’958 patent. A copy of the ’958 patent is attached hereto as Exhibit A. …Defendants. COMPLAINT FOR PATENT INFRINGEMENT Plaintiffs Senju Pharmaceutical…. The ’958 patent claims, inter alia, formulations of bromfenac for ophthalmic administration. Plaintiffs | External link to document | |
2019-01-02 | 7 | claims of U.S. Patent No. 8,|29,431 (“the ’431 Patent"), U.S. Patent No. 8,669,290 ("the ’290…290 Patent"), U.S. Patent No. 8,754,|31 (“the `I3l Patent"), U.S. Patent No. 8,871,813 (“the…the ’813 Patent”). U.S. Patent No. 8.927,606 ("the ’606 Patent”), U.S. Patent No. 9,144,609 (“the …the `609 Patent”). U.S. Patent No. 9,517,220 (“the ’220 Patent”), U.S. Patent No. 9,561,277 (“the ’277 Patent… Patent) and U.S. Patent No. lO, 085, 958 (“the `958 Patent") Case 3:18-cv-16991-BRI\/|-T.]B Document | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |